Abstract

Post-COVID conditions (PCCs) are persistent new patient symptoms occurring after acute COVID-19 infection and are an increasingly appreciated dimension of the COVID-19 pandemic. The factors that cause PCCs are not well understood. In recent work, Gebo et al. identify a connection between acute IL-6 levels, early COVID-19 convalescent plasma (CP) administration, and later PCCs in subjects from a randomized controlled trial of acutely ill subjects enrolled in 2020 to 2021 (K. A. Gebo, S. L. Heath, Y. Fukuta, X. Zhu, et al., mBio e00618-23, 2023, https://doi.org/10.1128/mbio.00618-23). These results may be viewed as part of an emerging picture linking the intensity of inflammatory responses during acute infection to later PCCs.

Original languageEnglish
JournalmBio
Volume14
Issue number5
DOIs
StatePublished - Oct 2023

Keywords

  • antiviral agents
  • convalescent plasma
  • COVID-19
  • post-COVID conditions

Fingerprint

Dive into the research topics of 'Igniting the slow burn of post-COVID conditions'. Together they form a unique fingerprint.

Cite this